Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea

Ryugyoung Lee,Minhee Ku,Nam Kyung Je
DOI: https://doi.org/10.1007/s00520-024-08367-9
IF: 3.1
2024-02-26
Supportive Care in Cancer
Abstract:Highly emetogenic chemotherapy (HEC) is known to induce nausea and vomiting (CINV) in approximately 90% of cancer patients undergoing this regimen unless proper prophylactic antiemetics are administered. This study aimed to analyze the use of a three-drug prophylactic antiemetic regimen during the first cycle of chemotherapy and assess the compliance rate with the National Comprehensive Cancer Network (NCCN) guidelines.
oncology,health care sciences & services,rehabilitation
What problem does this paper attempt to address?